The Trump administration has canceled $766 million awarded to drugmaker Moderna Inc. to develop a vaccine against potential pandemic influenza viruses, including H5N1 bird flu.

Amidst an ongoing outbreak of a deadly bird flu virus in livestock, the US Department of Agriculture is doing more to prevent ...

As bird flu continues to spread to chickens and dairy cows, scientists are in the process of developing the first mRNA bird flu vaccine for cattle.

The federal government announced Wednesday that it is canceling a contract to develop a vaccine ... people against flu strains with pandemic potential, including the H5N1 bird flu virus that's ...

Health Secretary Robert F. Kennedy Jr. has expressed deep skepticism regarding mRNA vaccines, despite real-world evidence ...

The H5N1 avian influenza virus has infected birds and mammals around the world. As of June 2025, 70 people have been infected ...

The US Department of Health and Human Services is terminating a contract with drugmaker Moderna to develop a vaccine to ...

The Trump administration has canceled a contract awarded to Moderna for the late-stage development of its bird flu vaccine for humans, as well as the right to purchase shots, the drugmaker announced ...

but not bird flu. In the U.S., the FDA have given approval for 3 vaccines against H5N1. However, the general public are not the target population for these vaccines. Instead, health experts ...

The safety of approved mRNA vaccines is well-established and, as with other vaccines, continues to be monitored by multiple ...